Name: Clinical Applications of Cardiovascular Drugs (en Inglés)
Price: 4174.29 MXN
Availability: InStock
Author: Dreifus, L. S. ; Brest, A. N.
ISBN: 9789024723690

Envío gratis

portada Clinical Applications of Cardiovascular Drugs (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Dreifus, L. S. ; Brest, A. N.

Idioma

Inglés

N° páginas

261

Encuadernación

Tapa Blanda

Dimensiones

23.4 x 15.6 x 1.4 cm

Peso

0.39 kg.

ISBN13

9789024723690

Categorías

Enfermedades cardiovasculares
Farmacología
Jardinería

Clinical Applications of Cardiovascular Drugs (en Inglés)

Dreifus, L. S. ; Brest, A. N. (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 4,174.29

$ 7,589.63

Ahorras: $ 3,415.33

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 22 de Julio y el Viernes 02 de Agosto.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Clinical Applications of Cardiovascular Drugs (en Inglés)"

During the past decade enormous progress has been made in the development of new cardiovascular drugs and in our understanding of the clinical pharma- cology and the pharmacokinetics of old drugs. In addition, newer applications of older agents have emerged. For example, vasodilators such as nitroglycerin are now being employed in the treatment of congestive heart failure, and anti- hypertensives such as bretylium are used in the management of ventricular arrhythmias. Individual chapters in this book focus on (1) the clinical pharmacology and pharmacokinetics of the individual drugs, and (2) the clinical applications of these drugs, with attention also to serum concentrations, pathophysiology, and drug interactions where appropriate. The contributors to this text have labored to provide the reader with a meaningful, practical update on the clinical uses and usefulness of cardioactive drugs. We are deeply grateful to each of them for their generous participation in this endeavor. LEONARD S. DREIFUS, M.D. ALBERT N. BREST, M.D. 1. ANTIARRHYTHMIC AGENTS LEONARD S. DREIFUS and JOEL MORGANROTH Ideally, the management of cardiac arrhythmias must be predicated on (1) complete elucidation of the genesis of the various rhythm disturbances, and (2) a full understanding of the pharmacologic action of individual antiarrhythmic agents. Only with this precise information does it become possible to administer a particular agent or agents specifically effective against a given arrhythmia.